Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
3(19%)
Results Posted
100%(9 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_2
9
56%
Ph phase_3
2
13%
Ph not_applicable
1
6%
Ph phase_1
1
6%
Ph phase_4
2
13%

Phase Distribution

1

Early Stage

9

Mid Stage

4

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
9(60.0%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
2(13.3%)
N/ANon-phased studies
1(6.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

3

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(9)
Terminated(2)
Other(2)

Detailed Status

Completed9
unknown2
Recruiting2
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
3
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.7%)
Phase 29 (60.0%)
Phase 32 (13.3%)
Phase 42 (13.3%)
N/A1 (6.7%)

Trials by Status

unknown213%
completed956%
recruiting213%
active_not_recruiting16%
terminated213%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT00882895Phase 2

Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Active Not Recruiting
NCT06463379Phase 3

The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis

Recruiting
NCT06456489Phase 3

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Recruiting
NCT04810156Phase 2

Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis

Unknown
NCT01319981Phase 2

Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia

Completed
NCT02464657Phase 1

Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Completed
NCT03876041Phase 4

Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome

Completed
NCT03942861

Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.

Unknown
NCT00671658Phase 2

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

Completed
NCT00185692Phase 2

Allogeneic Transplantation From Related Haploidentical Donors

Completed
NCT00807586Phase 4

Corticosteroid Pulse After Ablation

Completed
NCT02296346Not Applicable

Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis

Terminated
NCT00481832Phase 2

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Terminated
NCT00186628Phase 2

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Completed
NCT00899847Phase 2

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Completed
NCT01423864Phase 2

Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16